UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family

BBA - Molecular Cell Research, 2002-11, Vol.1592 (3), p.265-280

2002

Volltextzugriff (PDF)

IRAK-4: A Novel Member of the IRAK Family with the Properties of an IRAK-Kinase

Proceedings of the National Academy of Sciences - PNAS, 2002-04, Vol.99 (8), p.5567-5572

2002

Volltextzugriff (PDF)

IRAK-4 inhibitors for inflammation

Current topics in medicinal chemistry, 2009-05, Vol.9 (8), p.724-737

2009

Volltextzugriff (PDF)

Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2

The Journal of biological chemistry, 1999-06, Vol.274 (25), p.17406-17409

1999

Volltextzugriff (PDF)

Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors

Bioorganic & medicinal chemistry letters, 2012-10, Vol.22 (19), p.6212-6217

2012

Volltextzugriff (PDF)

Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide

The Journal of experimental medicine, 1998-12, Vol.188 (11), p.2091-2097

1998

Volltextzugriff (PDF)

Sphingosine kinase activity is not required for tumor cell viability

PloS one, 2013-07, Vol.8 (7), p.e68328

2013

Volltextzugriff (PDF)

Sequential Autophosphorylation Steps in the Interleukin-1 Receptor-associated Kinase-1 Regulate its Availability as an Adapter in Interleukin-1 Signaling

The Journal of biological chemistry, 2004-02, Vol.279 (7), p.5227-5236

2004

Volltextzugriff (PDF)

Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4

Bioorganic & medicinal chemistry letters, 2006-06, Vol.16 (11), p.2842-2845

2006

Volltextzugriff (PDF)

IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family

The Journal of biological chemistry, 1999-07, Vol.274 (27), p.19403-19410

1999

Volltextzugriff (PDF)

Metastatic Properties and Genomic Amplification of the Tyrosine Kinase Gene ACK1

Proceedings of the National Academy of Sciences - PNAS, 2005-11, Vol.102 (44), p.15901-15906

2005

Volltextzugriff (PDF)

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer

PloS one, 2009-05, Vol.4 (5), p.e5722-e5722

2009

Volltextzugriff (PDF)

T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities

Current opinion in oncology, 2022-09, Vol.34 (5), p.552-558

2022

Volltextzugriff (PDF)

867 TriTAC-XR is an extended-release T cell engager platform designed to minimize cytokine release syndrome by reducing Cmax in systemic circulation

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A908-A908

2021

Volltextzugriff (PDF)

632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A668-A668

2020

Volltextzugriff (PDF)

The Interleukin-1 Receptor Accessory Protein (IL-1RAcP) Is Essential for IL-1-induced Activation of Interleukin-1 Receptor-associated Kinase (IRAK) and Stress-activated Protein Kinases (SAP Kinases)

The Journal of biological chemistry, 1997-03, Vol.272 (12), p.7727-7731

1997

Volltextzugriff (PDF)

Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathways

PloS one, 2010-09, Vol.5 (9), p.e13024

2010

Volltextzugriff (PDF)

The Growth Factor Midkine Antagonizes VEGF Signaling In Vitro and In Vivo

Neoplasia (New York, N.Y.), 2008-04, Vol.10 (4), p.340,IN3-346,IN3

2008

Volltextzugriff (PDF)

High throughput screening for protein kinase inhibitors

Combinatorial chemistry & high throughput screening, 2005-03, Vol.8 (2), p.181-195

2005

Volltextzugriff (PDF)

Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors

Clinical cancer research, 2021-03, Vol.27 (5), p.1452-1462

2021

Volltextzugriff (PDF)

Meet The Guest Editors

Combinatorial chemistry & high throughput screening, 2008-03, Vol.11 (3), p.265-265

2008

Volltextzugriff (PDF)

Abstract 913: FLT3-targeting TriTACs are T cell engagers for treatment of acute myeloid leukemia

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.913-913

2021

Volltextzugriff (PDF)

TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors

Molecular cancer therapeutics, 2021-01, Vol.20 (1), p.109-120

2021

Volltextzugriff (PDF)

Identification of Essential Regions in the Cytoplasmic Tail of Interleukin-1 Receptor Accessory Protein Critical for Interleukin-1 Signaling

The Journal of biological chemistry, 2002-05, Vol.277 (19), p.16456-16463

2002

Volltextzugriff (PDF)

Abstract 3814: TriTACs are novel T cell-engaging therapeutic proteins optimized for the treatment of solid tumors and for long serum half-life

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3814-3814

2018

Volltextzugriff (PDF)

1 – 25 von 77

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(77)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(35)
Humans
(28)
Animals
(21)
Signal Transduction
(17)
Mice
(14)
Biochemistry & Molecular Biology
(13)
Physical Sciences
(10)
Immunology
(9)
Interleukin-1 Receptor-Associated Kinases
(9)
Biological And Medical Sciences
(8)
Multidisciplinary Sciences
(8)
Protein Kinases - Metabolism
(8)
Science & Technology - Other Topics
(8)
Structure-Activity Relationship
(8)
Cell Line
(7)
Chemistry
(7)
Drosophila Proteins
(7)
Medical Sciences
(7)
Nf-Kappa B - Metabolism
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family

IRAK-4: A Novel Member of the IRAK Family with the Properties of an IRAK-Kinase

IRAK-4 inhibitors for inflammation

Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2

Synthesis and optimization of substituted furo[2,3-d]-pyrimidin-4-amines and 7H-pyrrolo[2,3-d]pyrimidin-4-amines as ACK1 inhibitors

Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide

Sphingosine kinase activity is not required for tumor cell viability

Sequential Autophosphorylation Steps in the Interleukin-1 Receptor-associated Kinase-1 Regulate its Availability as an Adapter in Interleukin-1 Signaling

Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4

IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family

Metastatic Properties and Genomic Amplification of the Tyrosine Kinase Gene ACK1

Molecular signatures of prostate stem cells reveal novel signaling pathways and provide insights into prostate cancer

T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities

867 TriTAC-XR is an extended-release T cell engager platform designed to minimize cytokine release syndrome by reducing Cmax in systemic circulation

632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors

The Interleukin-1 Receptor Accessory Protein (IL-1RAcP) Is Essential for IL-1-induced Activation of Interleukin-1 Receptor-associated Kinase (IRAK) and Stress-activated Protein Kinases (SAP Kinases)

Molecular signatures of the primitive prostate stem cell niche reveal novel mesenchymal-epithelial signaling pathways

The Growth Factor Midkine Antagonizes VEGF Signaling In Vitro and In Vivo

High throughput screening for protein kinase inhibitors

Preclinical Characterization of HPN536, a Trispecific, T-Cell-Activating Protein Construct for the Treatment of Mesothelin-Expressing Solid Tumors

Meet The Guest Editors

Abstract 913: FLT3-targeting TriTACs are T cell engagers for treatment of acute myeloid leukemia

TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors

Identification of Essential Regions in the Cytoplasmic Tail of Interleukin-1 Receptor Accessory Protein Critical for Interleukin-1 Signaling

Abstract 3814: TriTACs are novel T cell-engaging therapeutic proteins optimized for the treatment of solid tumors and for long serum half-life

Suchergebnisse filtern